Tower Research Capital (TRC)’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$80.5K Buy
4,320
+3,317
+331% +$61.8K ﹤0.01% 2560
2025
Q1
$18.2K Sell
1,003
-376
-27% -$6.82K ﹤0.01% 3057
2024
Q4
$30.1K Sell
1,379
-944
-41% -$20.6K ﹤0.01% 2903
2024
Q3
$63.6K Buy
+2,323
New +$63.6K ﹤0.01% 2584
2024
Q2
Sell
-3,897
Closed -$117K 5743
2024
Q1
$117K Buy
3,897
+1,467
+60% +$44K ﹤0.01% 1746
2023
Q4
$25.3K Buy
+2,430
New +$25.3K ﹤0.01% 3515
2023
Q3
Sell
-762
Closed -$9.24K 5992
2023
Q2
$9.24K Sell
762
-62
-8% -$752 ﹤0.01% 4290
2023
Q1
$10K Sell
824
-1,602
-66% -$19.4K ﹤0.01% 4339
2022
Q4
$15K Buy
2,426
+1,639
+208% +$10.1K ﹤0.01% 3409
2022
Q3
$18K Buy
787
+30
+4% +$686 ﹤0.01% 4005
2022
Q2
$15K Buy
757
+577
+321% +$11.4K ﹤0.01% 4063
2022
Q1
$8K Sell
180
-1,584
-90% -$70.4K ﹤0.01% 4571
2021
Q4
$125K Buy
1,764
+1,678
+1,951% +$119K ﹤0.01% 2077
2021
Q3
$10K Sell
86
-538
-86% -$62.6K ﹤0.01% 4307
2021
Q2
$97K Buy
624
+194
+45% +$30.2K ﹤0.01% 2449
2021
Q1
$81K Buy
430
+334
+348% +$62.9K ﹤0.01% 2750
2020
Q4
$12K Sell
96
-353
-79% -$44.1K ﹤0.01% 4193
2020
Q3
$49K Sell
449
-53
-11% -$5.78K ﹤0.01% 3548
2020
Q2
$61K Buy
502
+178
+55% +$21.6K ﹤0.01% 2891
2020
Q1
$33K Buy
324
+285
+731% +$29K ﹤0.01% 1473
2019
Q4
$9K Sell
39
-37
-49% -$8.54K ﹤0.01% 2378
2019
Q3
$12K Buy
76
+68
+850% +$10.7K ﹤0.01% 2816
2019
Q2
$2K Sell
8
-42
-84% -$10.5K ﹤0.01% 3250
2019
Q1
$13K Buy
50
+37
+285% +$9.62K ﹤0.01% 2515
2018
Q4
$1K Sell
13
-19
-59% -$1.46K ﹤0.01% 3568
2018
Q3
$6K Buy
+32
New +$6K ﹤0.01% 3021